ACBM ACRO BIOMEDICAL CO., LTD.

CIK 0001622996 4 ready 8-Ks latest September 2, 2026, 4:05 PM ET RSS · JSON

Activity: NORMAL 0 filings / 30d vs 0 baseline Risk accumulating: auditor change (2)

Ready 8-Ks 4

Latest filing September 2, 2026, 4:05 PM ET

Top materiality 0.70

Event mix leadership ×2 · other_material ×1 · other ×1

Sentiment 0 pos · 1 neg · 3 neu

SHENANIGAN SCORE 1 / 7 see the board

Recent 8-K filings for ACBM

Highest-materiality recent filing

Acro Biomedical appoints new chairman and CEO; Su resigns

September 2, 2026, 4:05 PM ET leadership materiality 0.70 neutral item 5.02

Yu-Ting Su resigned as director, chairman, and CEO on Sept 2, 2026, effective immediately.
Board appointed Shao-Hsiang Shih as director and chairman, effective Sept 2, 2026.

September 2, 2026, 4:05 PM ET leadership materiality 0.70 neutral item 5.02

Acro Biomedical appoints new chairman and CEO; Su resigns

Yu-Ting Su resigned as director, chairman, and CEO on Sept 2, 2026, effective immediately.
January 8, 2026, 6:59 PM ET other material materiality 0.60 negative item 4.01 item 9.01 ◈ Auditor Changes ×2

Acro Biomedical dismisses auditor KCCW, engages Weinberg & Company

Dismissed KCCW Accountancy Corp. as independent auditor on January 4, 2026; no disagreements on accounting principles.
August 14, 2025, 7:59 PM ET leadership materiality 0.70 neutral item 5.02

ACRO Biomedical appoints Yu-Ting Su as CEO and chairman; Pao-Chi Chu resigns

Pao-Chi Chu resigned as director, chairman and CEO effective upon successor's appointment; resignation not due to any disagreement.
July 2, 2025, 7:59 PM ET other materiality 0.30 neutral item 4.01 item 9.01 ◈ Auditor Changes ×2

Acro Biomedical dismisses Prager Metis as auditor, engages KCCW

Dismissed Prager Metis CPAs as independent auditor effective June 30, 2025; no disagreements reported for 2024, 2023, or interim 2025.

Max materiality 0.70 · Median 0.65 · Most common event leadership

0 positive 1 negative 3 neutral